Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04533919 · ClinicalTrials.gov registry record
Validation of Pre-clinical Nano-Based Analgesics in Cells From Human Dorsal Root Ganglia
A clinical trial of Spinal Cord Neoplasm, sponsored by M.D. Anderson Cancer Center.
- Recruiting
- Registry status
- 8
- Enrollment target
- 1
- Study location
NCT04533919 is a study of Spinal Cord Neoplasm that is actively recruiting participants, run by M.D. Anderson Cancer Center. The registered enrollment target is 8 participants. The trial reports 1 study location across 1 state.
The verdict
NCT04533919, a study of Spinal Cord Neoplasm, is actively recruiting participants, sponsored by M.D. Anderson Cancer Center.
- RECRUITING
- Registry status
- 8 participants
- Enrollment target
- 1
- Study location
Study Summary
This study investigates the pre-clinical nano-based analgesics in cells from human dorsal root ganglia (clusters of neurons). Collecting these neurons may help future research related to safe and effective pain treatment.
Conditions Studied
Interventions
- PROCEDURE Biospecimen Collection
Study Locations (1)
Texas
- M D Anderson Cancer Center - Houston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 8 participants |
| Start Date | 2020-06-16 |
| Est. Completion | 2027-04-30 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04533919
The ClinicalTrials.gov registry entry for NCT04533919 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 8 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is M.D. Anderson Cancer Center, which has 2,692 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Spinal Cord Neoplasm appearing as the primary indexed condition, and to 1 intervention - of which Biospecimen Collection is the first listed.
NCT04533919 reports 1 study location spanning 1 distinct geographic area - top geographies include Texas.
Frequently Asked Questions
What is clinical trial NCT04533919 about?
NCT04533919 is a clinical study titled "Validation of Pre-clinical Nano-Based Analgesics in Cells From Human Dorsal Root Ganglia". This study investigates the pre-clinical nano-based analgesics in cells from human dorsal root ganglia (clusters of neurons). Collecting these neurons may help future research related to safe and effective pain treatment.
What is the current status of trial NCT04533919?
This trial is currently recruiting. The enrollment target is 8 participants. The study started on 2020-06-16. Estimated completion is 2027-04-30.
What conditions does trial NCT04533919 study?
This clinical trial studies the following conditions: Spinal Cord Neoplasm.
What interventions are being tested in trial NCT04533919?
The interventions under investigation include: Biospecimen Collection (PROCEDURE).
Who is sponsoring clinical trial NCT04533919?
This trial is sponsored by M.D. Anderson Cancer Center, which has 2,692 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04533919 being conducted?
This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.